ARCHIVES

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Wong To Head MSKCC Colorectal Service; How You Know When To Stop Advising NCI.

June 29, 2001

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

November 28, 1986